Active-ingredient Dossier
Levetiracetam
Active-ingredient Dossier for Levetiracetam (antiepileptic agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: LEVACTAM
- Brand: LEVETIRACETAM-AFT
- Brand: KEPPRA
- Brand: APO-Levetiracetam
- Brand: APO-LEVETIRACETAM
- Brand: HOSPIRA
- Therapeutic area: Neurology
What is
Levetiracetam Levetiracetam is an antiepileptic agent.
Australian brands containing
Levetiracetam — LEVACTAM — LEVETIRACETAM-AFT — KEPPRA — APO-Levetiracetam — APO-LEVETIRACETAM — HOSPIRA — LEVECEUMID — LEVEFINTAIC — LEVENAKAI — LEVERIUOL — LEVESINEAL — LEVETIRACETAM
Therapeutic areas
Levetiracetam is registered in neurology, with 35 brands containing this ingredient on the ARTG.
Sponsor landscape
Fourteen sponsors market levetiracetam in Australia, including Arrotex Pharmaceuticals, AdiraMedica, Strides Pharma Science, Micro Labs, Torrent, and Southern Cross Pharma.
PBS and regulatory activity
Two brands containing levetiracetam have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2008.